Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Jul 8, 2025 - 15:00

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.